NIA Funding Line Policy for FY 2018
NIA received a full year appropriation on March 23, 2018 of $2.574 billion, a $526 million increase over the FY 2017 level. The amount includes an additional $414 million for Alzheimer’s Disease research funding – including Alzheimer’s disease-related dementias.
NIH published the Fiscal Policy for Grant Awards – FY 2018 on May 16, 2018. Consistent with that policy, NIA is fully restoring cuts in non-competing awards made during prior continuing resolutions and paying future FY 2018 non-competing awards at the commitment level indicated on the Notice of Award.
NIA Competing Award Funding Policy
General Allocation: NIA is continuing a policy of holding to an average reduction of 18% on all competing research grant awards within the general allocation, with the exceptions of small grants awards (R03) and exploratory/developmental awards. These latter awards generally receive the study-section recommended amount of support. The 18% cut is an average. Individual awards are being reduced by more, or less than, that amount.
Alzheimer’s Allocation: NIA is awarding the study-section recommended amount of support within the Alzheimer’s allocation but with adjustments as deemed appropriate by staff.
September 2018 Update
NIA is reducing the average administrative cut on awards to 12% from 18%. This change affects all competing awards for FY 2018, both those already made and those yet to be made. As previously, NIA is not making administrative cuts to small grants (R03) or to exploratory/developmental awards (R21). These changes are to the average size of the cut. Individual awards may be cut by more, or less, than that amount.
General Allocation Update: Revised Funding Lines
NIA is paying most applications to the lines indicated. NIA may skip a few applications or award them R56 grants where consensus exists that the application needs to be improved prior to award. Similarly, NIA may pay a few applications beyond the funding line where any identified weaknesses may be addressed easily and the proposed research fits NIA’s published priorities.
General Pay line, < 500k | General Pay line, ≥ 500k | ADRD pay line, < 500k | ADRD pay line ≥ 500k | |
---|---|---|---|---|
All (except below) | 23% | 20% | 28% | 25% |
New Investigator R01s | 26% | 23% | 31% | 28% |
Early Stage Investigator R01s | 29% | 26% | 33% | 30% |
General pay line | ADRD pay line | |
---|---|---|
Program projects | 33 | 38 |
Other NIA-reviewed research | 33 | 38 |
General pay line | ADRD pay line | |
---|---|---|
Training grants | 21 | 35 |
Career awards | 21 | 28 |
Fellowships | 28 | 32 |
May 2018 Update
The tables below show NIA funding lines for FY 2018 for both the general allocation and for the Alzheimer’s allocation (which includes applications on dementias related to Alzheimer’s disease). The tables do not show funding lines for initiatives with set-asides. Contact your program officer for information on these applications.
We are paying most applications to the funding lines shown. For individual reasons, some applications within these lines may not be paid this year.
General Pay line, < 500k | General Pay line, ≥ 500k | ADRD pay line, < 500k | ADRD pay line ≥ 500k | |
---|---|---|---|---|
All (except below) | 19% | 16% | 28% | 25% |
New Investigator R01s | 22% | 19% | 31% | 28% |
Early Stage Investigator R01s | 25% | 22% | 33% | 30% |
General pay line | ADRD pay line | |
---|---|---|
Program projects | 31 | 38 |
Other NIA-reviewed research | 31 | 38 |
General pay line | ADRD pay line | |
---|---|---|
Training grants | 21 | 35 |
Career awards | 20 | 28 |
Fellowships | 28 | 32 |